Ozono Yoshinori, Kawakami Hiroshi, Uchiyama Naomi, Hatada Hiroshi, Ogawa Souichiro
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
J Gastroenterol. 2023 Nov;58(11):1081-1093. doi: 10.1007/s00535-023-02037-z. Epub 2023 Sep 12.
Comprehensive genomic profiling based on next-generation sequencing has recently been used to provide precision medicine for various advanced cancers. Endoscopic ultrasound (EUS)-guided fine-needle aspiration (EUS-FNA) and EUS-guided fine-needle biopsy (EUS-FNB) play essential roles in the diagnosis of abdominal masses, mainly pancreatic cancers. In recent years, CGP analysis using EUS-FNA/FNB specimens for hepatobiliary-pancreatic cancers has increased; however, the success rate of CGP analysis is not clinically satisfactory, and many issues need to be resolved to improve the success rate of CGP analysis. In this article, we review the transition from EUS-FNA to FNB, compare each test, and discuss the current status and issues in genomic analysis of hepatobiliary-pancreatic cancers using EUS-FNA/FNB specimens.
基于新一代测序的综合基因组分析最近已被用于为各种晚期癌症提供精准医疗。超声内镜(EUS)引导下细针穿刺抽吸术(EUS-FNA)和超声内镜引导下细针活检术(EUS-FNB)在腹部肿块(主要是胰腺癌)的诊断中发挥着重要作用。近年来,使用EUS-FNA/FNB标本进行肝胆胰癌的CGP分析有所增加;然而,CGP分析的成功率在临床上并不令人满意,需要解决许多问题以提高CGP分析的成功率。在本文中,我们回顾了从EUS-FNA到FNB的转变,比较了各项检查,并讨论了使用EUS-FNA/FNB标本进行肝胆胰癌基因组分析的现状和问题。
J Surg Case Rep. 2025-7-24
Diagnostics (Basel). 2024-5-31
Chin Clin Oncol. 2023-4
Explor Target Antitumor Ther. 2021
Am J Transl Res. 2022-7-15